Insight Molecular Diagnostics Inc. — Director's Dealing 2022

Dec 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oncocyte Corp (OCX)
CIK: 0001642380
Period of Report: 2022-12-22

Reporting Person: KINGSLEY ALFRED D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-22	Common Stock, no par value	P	25000	$0.285	Acquired	439111	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, no par value	75345	Indirect
Common Stock, no par value	18767	Indirect

Footnotes

F1: The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.

F2: The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.